# Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

> **NCT00196768** · PHASE4 · UNKNOWN · sponsor: **German AML Cooperative Group** · enrollment: 30 (estimated)

## Conditions studied

- Relapsed Acute Promyelocytic Leukemia
- Refractory Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** Arsenic trioxide
- **DRUG:** Trisenox

## Key facts

- **NCT ID:** NCT00196768
- **Lead sponsor:** German AML Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196768, "Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00196768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*